Aujan Mehregan
Global Head of Inside Sales & Market Development Nuclera
Seminars
Thursday 30th April 2026
Active, Monomeric GPCRs in
10:00 am
- Producing active GPCRs by co‑translating receptors directly into MSP–lipid nanodiscs, avoiding detergents and preserving native-like stability
- Multiplexing 11 constructs across 8 lipid environments via automated CFPS–nanodisc screening to rapidly identify optimal biophysical conditions
- Delivering assay‑ready GPCRs in 48 hours, enabling high‑yield, functional β1AR and FFAR1 production for drug discovery and structural studies
